SAN FRANCISCO   â€”    Innate Immunotherapeutics is a tiny pharmaceutical company from Australia that has no approved drugs and no backing from flashy venture capital firms, and trades for just over a dollar a share on the Australian Stock Exchange. More than once, the company has run out of money and nearly closed its doors. 